People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cleave Biosciences, Inc. | — | Biotechnology | Series B | $37.9M | $475.1M | 2016 |
Mark Rolfe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Rolfe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Root | 1 | 16 |
| Andrew Schwab | 1 | 16 |
| Peter Thompson | 1 | 16 |
| Laura Shawver | 1 | 6 |
| Carol Gallagher | 1 | 6 |
| Timothy Smith | 1 | 5 |
| DENNIS HENNER | 1 | 5 |
| Lewis Shuster | 1 | 2 |
| Alfred Scheidegger | 1 | 1 |
| Amy Burroughs | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.